降钙素原
医学
内科学
社区获得性肺炎
免疫系统
肺炎
逻辑回归
中性粒细胞绝对计数
风险因素
肺炎严重指数
胃肠病学
免疫学
败血症
毒性
中性粒细胞减少症
作者
Tingting Ding,Lei Gao,Ling Zheng,Jing Ye,Hui Zhao
出处
期刊:PubMed
[National Institutes of Health]
日期:2019-06-01
卷期号:31 (6): 684-688
被引量:3
标识
DOI:10.3760/cma.j.issn.2095-4352.2019.06.005
摘要
OBJECTIVE: To analyze the characteristics of cellular immune function and its prognostic risk factors in patients with community-acquired pneumonia (CAP). METHODS: The clinical data of patients diagnosed as CAP admitted to department of respiratory and critical care medicine of the Second Affiliated Hospital of Anhui Medical University from June 2018 to February 2019 were retrospectively analyzed. The patients were divided into survival group and death group according to the mortality at discharge and 28-day survival after hospital discharge; in addition, they were divided into bacterial group, fungi group and mixed infection group according to pathogen results at discharge. The differences of general clinical characteristics, arterial blood gas analysis indexes, plasma albumin, cellular immune function, inflammatory cytokines, the length of hospital stay among groups were analyzed. The correlation between the prognosis-related indicators in patients were analyzed by Pearson test or Spearman test, and Logistic regression model was used to analyze the risk factors of patients in non-survival group. RESULTS: T cell count (r = -0.354, P < 0.05), CRP and the length of hospital stay (r = -0.356, P < 0.05). There were no significant correlations between the others. There was no significant difference in cellular immune function or inflammatory factor expression between different pathogenic infections. CONCLUSIONS: Cellular immune dysfunction, hypoproteinemia, APACHE II score and elevated inflammatory index are all influential factors for the death of CAP patients. Apart from conventional anti-infective treatment, the symptoms of hypoproteinemia and cellular immune function can predict the severity and prognosis of CAP patients.
科研通智能强力驱动
Strongly Powered by AbleSci AI